Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

HIV treatment news

Show

From To
What can science learn from a child who has controlled HIV without drugs for more than 8 years?

An HIV-infected child in South Africa who is controlling the virus without antiretroviral (ARV) drugs has reinvigorated the push to find ways to allow people to control the virus for prolonged periods without treatment.

Published
2 hours ago
From
Science
Doravirine combination pill looks good for initial HIV treatment

A single-tablet regimen containing the next-generation NNRTI doravirine reduced HIV viral load as much as an efavirenz-based coformulation, but it had a more favourable side-effect profile, according

Published
3 hours ago
By
Liz Highleyman
Acute kidney injury ‘uncommon’ but unpredictable on tenofovir and ritonavir

Doctors need to monitor patients regularly for kidney function if they are taking tenofovir disoproxil, especially if combined with ritonavir, the 9th International AIDS Society Conference on HIV

Published
5 hours ago
By
Gus Cairns
Antibody helps keep man's HIV at bay for 10 months

An experimental therapy has held back one man's HIV infection for 10 months, doctors have reported. He was one of 18 people in a small trial testing injections of "broadly neutralising antibodies" - the natural weapons of the immune system.

Published
26 July 2017
From
BBC News
Integrase inhibitors not causing higher rates of adverse birth outcomes, Botswana and French studies show

Dolutegravir-based antiretroviral therapy (ART) started in pregnancy is as safe as efavirenz-based ART, according to a study of birth outcomes at eight maternity wards throughout Botswana accounting for

Published
25 July 2017
By
Carole Leach-Lemens
New guidance says start HIV treatment within 7 days of diagnosis – but is everyone ready?

Everyone diagnosed with HIV should be offered the option to start treatment within seven days of diagnosis and everyone who feels ready should have the option to

Published
25 July 2017
By
Keith Alcorn
International study of gay couples reports no transmissions from an HIV-positive partner on treatment

A study of 343 gay couples, where one partner had HIV and the other did not, has not found a single case of HIV transmission in

Published
25 July 2017
By
Gus Cairns
New integrase inhibitor bictegravir works well for first-line HIV treatment

A single-tablet regimen containing the experimental integrase inhibitor bictegravir was as effective as two widely used approved regimens for first-line therapy in a pair of phase 3 clinical

Published
25 July 2017
By
Liz Highleyman
South African child has controlled HIV off treatment for 8.5 years

A nine-year-old South African child who was diagnosed with HIV infection at one month of age and received HIV treatment for 40 weeks during infancy has suppressed the virus

Published
24 July 2017
By
Keith Alcorn
Less frequent clinic visits for HIV care: fine tuning needed

Shifts to less frequent clinic visits and medication pick-ups to free up healthcare resources and make life easier for people living with HIV are being implemented successfully

Published
24 July 2017
By
Keith Alcorn
← First12345...447Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.